Literature DB >> 32923879

Long-Lasting Response to Nivolumab for a Patient With Lynch Syndrome-Associated Lung Adenocarcinoma.

Keita Masuzawa1, Takanori Asakura1, Shinnosuke Ikemura1, Hiroyuki Yasuda1, Ichiro Kawada1, Sosuke Takaoka1, Yuichiro Hayashi1, Takeshi Nakajima2, Masami Arai2,3, Koichi Fukunaga1, Kenzo Soejima1.   

Abstract

Entities:  

Year:  2020        PMID： 32923879      PMCID： PMC7446384          DOI： 10.1200/PO.19.00156

Source DB:  PubMed          Journal:  JCO Precis Oncol        ISSN： 2473-4284


× No keyword cloud information.
  34 in total

1.  The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC).

Authors:  H F Vasen; J P Mecklin; P M Khan; H T Lynch
Journal:  Dis Colon Rectum       Date:  1991-05       Impact factor: 4.585

2.  Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

Authors:  Liufu Deng; Hua Liang; Byron Burnette; Michael Beckett; Thomas Darga; Ralph R Weichselbaum; Yang-Xin Fu
Journal:  J Clin Invest       Date:  2014-01-02       Impact factor: 14.808

3.  Clinical outcome in patients with intramedullary spinal cord metastases from lung cancer.

Authors:  C Conill; J Marruecos; E Verger; J Berenguer; F Lomeña; J Domingo-Domènech; J J Grau; F Casas
Journal:  Clin Transl Oncol       Date:  2007-03       Impact factor: 3.405

4.  EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer.

Authors:  Shun Lu; Yongfeng Yu; Ziming Li; Ruoying Yu; Xue Wu; Hairong Bao; Yan Ding; Yang W Shao; Hong Jian
Journal:  J Thorac Oncol       Date:  2019-01-02       Impact factor: 15.609

5.  Identification of Lynch syndrome among patients with colorectal cancer.

Authors:  Leticia Moreira; Francesc Balaguer; Noralane Lindor; Albert de la Chapelle; Heather Hampel; Lauri A Aaltonen; John L Hopper; Loic Le Marchand; Steven Gallinger; Polly A Newcomb; Robert Haile; Stephen N Thibodeau; Shanaka Gunawardena; Mark A Jenkins; Daniel D Buchanan; John D Potter; John A Baron; Dennis J Ahnen; Victor Moreno; Montserrat Andreu; Maurizio Ponz de Leon; Anil K Rustgi; Antoni Castells
Journal:  JAMA       Date:  2012-10-17       Impact factor: 56.272

6.  Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.

Authors:  Hossein Borghaei; Luis Paz-Ares; Leora Horn; David R Spigel; Martin Steins; Neal E Ready; Laura Q Chow; Everett E Vokes; Enriqueta Felip; Esther Holgado; Fabrice Barlesi; Martin Kohlhäufl; Oscar Arrieta; Marco Angelo Burgio; Jérôme Fayette; Hervé Lena; Elena Poddubskaya; David E Gerber; Scott N Gettinger; Charles M Rudin; Naiyer Rizvi; Lucio Crinò; George R Blumenschein; Scott J Antonia; Cécile Dorange; Christopher T Harbison; Friedrich Graf Finckenstein; Julie R Brahmer
Journal:  N Engl J Med       Date:  2015-09-27       Impact factor: 91.245

7.  Increased mutation rate at the hprt locus accompanies microsatellite instability in colon cancer.

Authors:  J R Eshleman; E Z Lang; G K Bowerfind; R Parsons; B Vogelstein; J K Willson; M L Veigl; W D Sedwick; S D Markowitz
Journal:  Oncogene       Date:  1995-01-05       Impact factor: 9.867

8.  Microsatellite instability in pulmonary adenocarcinomas: a comprehensive study of 480 cases.

Authors:  Arne Warth; Sandrina Körner; Roland Penzel; Thomas Muley; Hendrik Dienemann; Peter Schirmacher; Magnus von Knebel-Doeberitz; Wilko Weichert; Matthias Kloor
Journal:  Virchows Arch       Date:  2015-12-04       Impact factor: 4.064

9.  Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer.

Authors:  Alicia Latham; Preethi Srinivasan; Yelena Kemel; Jinru Shia; Chaitanya Bandlamudi; Diana Mandelker; Sumit Middha; Jaclyn Hechtman; Ahmet Zehir; Marianne Dubard-Gault; Christina Tran; Carolyn Stewart; Margaret Sheehan; Alexander Penson; Deborah DeLair; Rona Yaeger; Joseph Vijai; Semanti Mukherjee; Jesse Galle; Mark A Dickson; Yelena Janjigian; Eileen M O'Reilly; Neil Segal; Leonard B Saltz; Diane Reidy-Lagunes; Anna M Varghese; Dean Bajorin; Maria I Carlo; Karen Cadoo; Michael F Walsh; Martin Weiser; Julio Garcia Aguilar; David S Klimstra; Luis A Diaz; Jose Baselga; Liying Zhang; Marc Ladanyi; David M Hyman; David B Solit; Mark E Robson; Barry S Taylor; Kenneth Offit; Michael F Berger; Zsofia K Stadler
Journal:  J Clin Oncol       Date:  2018-10-30       Impact factor: 50.717

10.  Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome.

Authors:  Kyoung Jin Park; Hyun Jung Choi; Soon Pal Suh; Chang Seok Ki; Jong Won Kim
Journal:  Ann Lab Med       Date:  2016-09       Impact factor: 3.464
View more
  3 in total

1.  Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type.

Authors:  Elena Maccaroni; Edoardo Lenci; Veronica Agostinelli; Valeria Cognigni; Riccardo Giampieri; Paola Mazzanti; Marzia Di Pietro Paolo; Francesca Bianchi; Cristiana Brugiati; Laura Belvederesi; Silvia Pagliaretta; Alessandra Mandolesi; Marina Scarpelli; Alberto Murrone; Francesca Morgese; Zelmira Ballatore; Rossana Berardi
Journal:  Explor Target Antitumor Ther       Date:  2021-06-28

Review 2.  An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome.

Authors:  Christina Therkildsen; Lars Henrik Jensen; Maria Rasmussen; Inge Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2021-05-24

3.  Case Report and Literature Review: Diagnosis, Tailored Genetic Counseling and Cancer Prevention for a Locally Advanced dMMR/MSI-H/TMB-H Lung Cancer Patient With Concurrent Lynch Syndrome Mediated by a Rare PMS2 Splicing Variant (c.1144+1G>A).

Authors:  Quanli Han; Si Liu; Zhi Cui; Qi Wang; Tonghui Ma; Liwen Jiang; Xiaomo Li; Guanghai Dai
Journal:  Front Genet       Date:  2022-01-18       Impact factor: 4.599
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.